Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Berardi, Rossana, Onofri, Azzurra, Pistelli, Mirco, Maccaroni, Elena, Scartozzi, Mario, Pierantoni, Chiara, Cascinu, Stefano
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2010
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963923/
https://ncbi.nlm.nih.gov/pubmed/21042543
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items